150 related articles for article (PubMed ID: 7882774)
1. [Flow cytometric quantitation of p53 protein expression in gastrointestinal smooth muscle tumors: clinicopathological correlation and prognostic significance].
Cai JH; Jiang YK; Zhang YY
Zhonghua Wai Ke Za Zhi; 1994 Aug; 32(8):483-6. PubMed ID: 7882774
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of P53 protein expression in gastrointestinal smooth muscle tumors. Clinicopathological correlation and prognostic significance.
Cai J; Jiang Y; Zhang Y; Lu G; Zhang X; Gao Q; Zuo L
Chin Med J (Engl); 1995 Sep; 108(9):669-73. PubMed ID: 8575232
[TBL] [Abstract][Full Text] [Related]
3. Smooth muscle tumors of the gastrointestinal tract. Expression of ras P21 oncogene product and the association with clinicopathology.
Cai JH; Jiang YK; Zhang YY; Lu GH; Zhang XH; Gao QZ; Zuo LF
Chin Med J (Engl); 1994 Sep; 107(9):683-7. PubMed ID: 7805461
[TBL] [Abstract][Full Text] [Related]
4. [Quantitation of Ras p21 oncogene and DNA content of gastrointestinal smooth muscle tumors and prognostic significance].
Cai J; Jiang Y; Zhang Y
Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):225-8. PubMed ID: 7587676
[TBL] [Abstract][Full Text] [Related]
5. Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract.
Kimura H; Yonemura Y; Kadoya N; Kosaka T; Miwa K; Miyazaki I; Sawa T; Yoshimitsu S; Nishida Y; Kamata T
Anal Cell Pathol; 1993 Nov; 5(6):331-8. PubMed ID: 8305329
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
7. [Expression of nm23 in gastrointestinal smooth muscle tumors and its relation to cell proliferative activity].
Wang Q; Sun W; Zhao Y; Wang M; Qin Y; Fu Y
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):427-9. PubMed ID: 11825432
[TBL] [Abstract][Full Text] [Related]
8. Smooth muscle tumors of the gastrointestinal tract. Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade.
Kiyabu MT; Bishop PC; Parker JW; Turner RR; Fitzgibbons PL
Am J Surg Pathol; 1988 Dec; 12(12):954-60. PubMed ID: 3202248
[TBL] [Abstract][Full Text] [Related]
9. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
[TBL] [Abstract][Full Text] [Related]
10. [Gastrointestinal smooth muscle tumors: a study of DNA content and the association with clinicopathology].
Cai J; Jiang Y; Zhang Y
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):378-80. PubMed ID: 8732098
[TBL] [Abstract][Full Text] [Related]
11. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
12. [DNA flow cytometry in smooth muscle tumors of the gastrointestinal tract].
Sugihira N; Matsumoto K; Tada T; Fujino I; Urata H; Yamamoto T; Suzuki H
Gan To Kagaku Ryoho; 1993 Apr; 20(6):713-6. PubMed ID: 8489272
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.
Zhai YL; Nikaido T; Toki T; Shiozawa A; Orii A; Fujii S
Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
15. [Analysis for predicting the prognostic factors of gastrointestinal tract leiomyosarcoma using MIB-1 and DNA flow cytometry].
Nishio T; Nakagomi H; Mutou S; Miyake T; Hagiwara J; Ashizawa I; Oyama T; Takano K; Tada Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():475-80. PubMed ID: 9589056
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
Petrović D; Babić D; Forko JI; Martinac I
Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
Chou FF; Eng HL; Sheen-Chen SM
Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
[TBL] [Abstract][Full Text] [Related]
20. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
Amada S; Nakano H; Tsuneyoshi M
Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
